Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 36,629 | 26,882 | 17,245 | 16,480 | 863 |
| Cost of Goods | 10,532 | 6,125 | 3,658 | 790 | 0 |
| Gross Profit | 26,097 | 20,757 | 13,587 | 15,690 | 863 |
| Operating Expenses | 137,448 | 140,879 | 104,041 | 82,190 | 51,394 |
| Operating Income | -110,819 | -119,997 | -89,796 | -65,710 | -50,531 |
| Interest Expense | 11,849 | 10,340 | 7,687 | 3,689 | 1,484 |
| Other Income | 21,008 | -463 | -30 | -1,891 | -1,868 |
| Pre-tax Income | -101,660 | -130,800 | -97,513 | -71,290 | -53,883 |
| Net Income Continuous | -101,660 | -130,800 | -97,513 | -71,290 | -53,883 |
| Net Income Discontinuous | N/A | -11,136 | -2,323 | N/A | N/A |
| Minority Interests | -61,700 | -57,789 | -32,960 | -16,195 | -5,455 |
| Net Income | $-39,960 | $-84,147 | $-66,876 | $-55,095 | $-48,428 |
| EPS Basic Total Ops | -10.94 | -29.09 | -24.14 | -20.69 | -18.59 |
| EPS Basic Continuous Ops | -27.86 | -45.13 | -35.09 | -26.75 | -20.64 |
| EPS Basic Discontinuous Ops | N/A | -3.90 | -0.84 | N/A | N/A |
| EPS Diluted Total Ops | -10.94 | -29.09 | -24.14 | -20.69 | -18.59 |
| EPS Diluted Continuous Ops | -27.86 | -45.13 | -35.09 | -26.75 | -20.64 |
| EPS Diluted Discontinuous Ops | N/A | -3.90 | -0.84 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -10.95 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-102,844 | $-115,519 | $-85,395 | $-62,955 | $-50,191 |